Header Logo

Connection

ROBERT BRESALIER to CTLA-4 Antigen

Back to Details
This is a "connection" page, showing publications ROBERT BRESALIER has written about CTLA-4 Antigen.
ROBERT BRESALIER
Connection Strength
0.032
CTLA-4 Antigen
  1. Early introduction of selective immunosuppressive therapy associated with favorable clinical outcomes in patients with immune checkpoint inhibitor-induced colitis. J Immunother Cancer. 2019 04 02; 7(1):93.
    View in: PubMed
    Score: 0.032
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.